FIELD: medicine.
SUBSTANCE: what is offered is application of 9-(3,4-dihydroxyphenacyl)-2,3-dihydroimidazo[1,2-a] benzimidazole hydrobromide of formula I 
as a compound possessing antithrombogenic activity. The compound is applicable as an active principle of drugs for therapy of thromboses. Activity of the compound exceeds acetylsalicylic acid and diabenol.
EFFECT: higher antithrombogenic activity in the conditions of arterial thrombosis.
2 cl, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
| HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
| ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
| DICALCIUM SALT OF N-(3-HYDROXYBENZOYL)TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY IN COMBINATION WITH CEREBROPROTECTIVE ACTION | 2019 |
|
RU2730835C1 |
| 1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
| DIPOTASSIUM SALT OF N-(4-HYDROXYBENZOYL) TAURINE, HAVING ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2019 |
|
RU2731106C1 |
| AGENT EXHIBITING ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2014 |
|
RU2573379C1 |
